Hexamethylmelamine
Hexamethylmelamine (HMM), also known as altretamine, is a synthetic derivative of melamine. Its chemical structure consists of a melamine ring with six methyl groups attached. HMM was developed as an antineoplastic agent, meaning it was investigated for its potential to treat cancer.
The primary medical application of hexamethylmelamine was in the treatment of ovarian cancer, particularly in cases
In clinical trials, hexamethylmelamine demonstrated some efficacy in patients with advanced ovarian cancer. However, its use